Neurometabolic Disorders-Related Early Childhood Epilepsy: A Single-Center Experience in Saudi Arabia

Sarar Mohamed1, Ebtessam M El Melegy2, Iman Talaat2

  • 1Department of Pediatrics, College of Medicine, King Saud University, Riyadh, Saudi Arabia; Department of Pediatrics, Saad Specialist Hospital, Al Khobar, Saudi Arabia.

Insights

Metabolic disorders are a significant cause of epilepsy in young children, particularly in developing nations. This study highlights key clinical and molecular features of these conditions in infants and toddlers.

Area of Science:

  • Pediatric Neurology
  • Metabolic Disorders
  • Epilepsy Etiology

Background:

  • Limited data exists on epilepsy patterns from metabolic disorders in early childhood in developing countries.
  • Understanding these causes is crucial for early diagnosis and intervention.

Purpose of the Study:

  • To identify metabolic causes of epilepsy in children under two years old.
  • To characterize their clinical, radiological, molecular, and electroencephalographic features.

Main Methods:

  • Retrospective study of 221 children with epilepsy onset before age two.
  • Exclusion of febrile convulsions based on International League Against Epilepsy criteria.
  • Diagnostic confirmation through DNA studies and enzyme assays.

Main Results:

  • 24 out of 221 children (10.8%) had epilepsy due to metabolic disorders.
  • Consanguinity (75%) and developmental delay (54%) were common.
  • Peroxisomal disorders, nonketotic hyperglycinemia, Menkes disease, and biotinidase deficiency were among the identified diagnoses.
  • Seizure freedom was achieved in one-third of the patients.

Conclusions:

  • Metabolic disorders represent a notable cause of early-onset epilepsy.
  • Specific metabolic conditions are associated with particular seizure types, including myoclonic seizures and infantile spasms.
Abstract

Related Concept Videos